Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study. Nexviazyme met its primary endpoint, participants alive and free of i ...
yt-dlp is powerful, but its command-line interface can be intimidating. yt-dlp GUI wraps it in a clean, native desktop app — no terminal needed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results